Nvidia on Monday unveiled a new family of open-source artificial intelligence models that it says will be faster, cheaper and smarter than its previous offerings, as open-source offerings from Chinese ...

In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...

Nvidia said on Monday it acquired AI software firm SchedMD, as the chip designer doubles down on open-source technology and steps up investments in the artificial intelligence ecosystem to fend off ...

Physicists are quietly rolling out a new generation of simulation codes that promise to do more than crunch numbers. By ...

Even most rocket scientists would rather avoid hard math when they don't have to do it. So when it comes to figuring out ...

Seattle biotech startup Rhizome Research has emerged from stealth with technology for creating small-molecule drug candidates ...

Nvidia Corporation remains a Strong Buy with reasonable P/E ratios, robust AI leadership, and expected double-digit returns.

Lux and Discovery are engineered for scientific workloads that now pair high-fidelity simulation with large AI models, ...

Join the audience for a live webinar at 3 p.m. GMT/10 a.m. EST on 21 January 2026 Discover the role of impedance analysis in advancing battery-model development ...

Here is the AI research roadmap for 2026: how agents that learn, self-correct, and simulate the real world will redefine business automation.

Exclusive: Australian scientists are working alongside China’s top military university – the one answering to Xi Jinping’s ...

Nvidia (NASDAQ:NVDA) owns a growing portfolio of strategic equity investments in companies supporting the broader artificial ...